MG
COLL icon

Michael Gelband’s Collegium Pharmaceutical COLL Stock Holding History

Michael Gelband’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-105,185
Closed -$4.87M – 1633
2025
Q4 		$4.87M Buy
105,185
+89,383
+566% +$3.74M 0.04% 479
2025
Q3 		$553K Buy
+15,802
New +$549K 0.01% 1150
2025
Q2 		– Sell
-196,491
Closed -$5.87M – 1537
2025
Q1 		$5.87M Buy
196,491
+133,252
+211% +$4.07M 0.06% 364
2024
Q4 		$1.81M Sell
63,239
-4,213
-6% -$139K 0.01% 750
2024
Q3 		$2.61M Buy
+67,452
New +$2.41M 0.02% 631
2024
Q2 		– Sell
-88,603
Closed -$3.44M – 1590
2024
Q1 		$3.44M Buy
88,603
+50,351
+132% +$1.76M 0.03% 514
2023
Q4 		$1.18M Buy
+38,252
New +$958K 0.01% 753
2023
Q3 		– Sell
-14,324
Closed -$308K – 1759
2023
Q2 		$308K Sell
14,324
-30,667
-68% -$696K ﹤0.01% 1532
2023
Q1 		$1.08M Buy
+44,991
New +$1.19M 0.01% 1116
2022
Q3 		– Sell
-10,012
Closed -$177K – 1932
2022
Q2 		$177K Sell
10,012
-888
-8% -$14.9K ﹤0.01% 1679
2022
Q1 		$222K Sell
10,900
-17,721
-62% -$335K ﹤0.01% 1869
2021
Q4 		$535K Buy
+28,621
New +$558K 0.01% 1359
2021
Q1 		– Sell
-10,416
Closed -$209K – 2168
2020
Q4 		$209K Sell
10,416
-17,489
-63% -$341K ﹤0.01% 1708
2020
Q3 		$581K Buy
+27,905
New +$504K 0.01% 936

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Michael Gelband's COLL Position: Q1 2026 in Review

Michael Gelband sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 105,185 shares — an estimated $4.87M sold.

Michael Gelband first reported a position in COLL in Q3 2020 and held it in 14 quarters. The position peaked at $5.87M in Q1 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Michael Gelband reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 105,185 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.87M.
  • Michael Gelband first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 14 quarters.
  • Michael Gelband's Collegium Pharmaceutical position peaked at $5.87M in Q1 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.